Guidelines for maternal codeine use during breastfeeding
P Madadi, M Moretti, N Djokanovic, P Bozzo… - Canadian Family …, 2009 - cfp.ca
ABSTRACT QUESTION In light of the recent evidence of adverse events in infants whose
mothers use codeine medication, we have been struggling with the issue of how to manage …
mothers use codeine medication, we have been struggling with the issue of how to manage …
Establishing causality of CNS depression in breastfed infants following maternal codeine use
P Madadi, F Shirazi, FG Walter, G Koren - Pediatric Drugs, 2008 - Springer
Background: We recently reported on a breastfed infant who succumbed to opioid toxicity
following exposure to morphine, the active metabolite of codeine, which was prescribed to …
following exposure to morphine, the active metabolite of codeine, which was prescribed to …
Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine
P Madadi, G Koren, J Cairns, D Chitayat… - Canadian Family …, 2007 - cfp.ca
QUESTION Recently a newborn died from morphine poisoning when hismother used
codeine while breastfeeding. Many patients receive codeine for postlabour pain. Is it safe to …
codeine while breastfeeding. Many patients receive codeine for postlabour pain. Is it safe to …
[HTML][HTML] A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk
Background Neonates are commonly exposed to maternal codeine through breast milk.
Central Nervous System (CNS) depression has been reported in up to 24% of nurslings …
Central Nervous System (CNS) depression has been reported in up to 24% of nurslings …
Safety issues of maternal drug therapy during breastfeeding
CM Berlin Jr, IM Paul, ES Vesell - Clinical Pharmacology & …, 2009 - Wiley Online Library
Two goals when counseling breastfeeding mothers taking medication are protecting the
infant from adverse events and permitting necessary maternal therapy. Madadi et al. report a …
infant from adverse events and permitting necessary maternal therapy. Madadi et al. report a …
Postpartum maternal codeine therapy and the risk of adverse neonatal outcomes: a retrospective cohort study
Objectives. To examine whether postpartum maternal prescription of codeine was
associated with an increased risk of harm to newborns. Design. Population-based …
associated with an increased risk of harm to newborns. Design. Population-based …
Codeine should not be prescribed for breastfeeding mothers or children under the age of 12
M Lazaryan, C Shasha‐Zigelman, Z Dagan… - Acta …, 2015 - Wiley Online Library
Medical regulatory authorities, including the Food and Drug Administration and European
Medicine Agency, have published restrictions regarding the use of codeine in paediatric …
Medicine Agency, have published restrictions regarding the use of codeine in paediatric …
Is it safe to use opioids for obstetric pain while breastfeeding?
JN van den Anker - The Journal of pediatrics, 2012 - jpeds.com
The report by Lam et al in this issue of The Journal examines central nervous system (CNS)
depression of neonates who were breastfed by their mothers receiving oxycodone for …
depression of neonates who were breastfed by their mothers receiving oxycodone for …
Codeine and the breastfed neonate
RG Meny, EG Naumburg, LS Alger… - Journal of Human …, 1993 - journals.sagepub.com
Codeine is an analgesic commonly used to relieve pain in the early post partum. Its
metabolite, morphine, is probably responsible for its effectiveness in this use. However …
metabolite, morphine, is probably responsible for its effectiveness in this use. However …
[CITATION][C] Antenatal and postnatal analgesia: scientific impact paper no. 59
DL Bisson, SD Newell, C Laxton… - … Journal of Obstetrics …, 2019 - Wiley Online Library
Traditionally, codeine has been used extensively for antenatal and postnatal pain relief.
However, in 2013 the Medicines and Healthcare products Regulatory Authority (MHRA) 1 …
However, in 2013 the Medicines and Healthcare products Regulatory Authority (MHRA) 1 …